Diabetic Retinopathy
Donald S. Fong, Ronald Klein(University of Wisconsin–Madison), Thomas W. Gardner(University of Michigan), Lloyd Paul Aiello(Joslin Diabetes Center), George W. Blankenship, Jerry D. Cavallerano, George L. King(Joslin Diabetes Center)
Cited by 231
Related Papers
Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis
|The Lancet Global Health|2014|5.2k
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
|New England Journal of Medicine|1994|3.8k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k
Retinopathy in Diabetes
|Diabetes Care|2004|1.1k